시장보고서
상품코드
2058640

핵의학 영상 진단 장비 시장 : 종류별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Nuclear Imaging Equipment Market, By, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 328 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 5,031,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 금액 안내 화살표 ₩ 7,199,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,747,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

핵의학 영상 진단 장비 시장 규모는 2025년에 34억 1,282만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 7.23%로 확대될 것으로 전망됩니다.

핵의학 영상 진단 장비는 방사성 추적자를 투여한 후 체내에서 방출되는 방사선을 감지하기 위해 설계된 특수 의료기기입니다. 이러한 장비는 장기나 조직의 매우 상세한 3D 기능 지도 및 생리학적 지도를 생성하여, 암이나 심장병 등의 질환 진단 및 경과 관찰에 활용됩니다. 2026년 2월에 발표된 PwC의 '세계 산업 제조 부문 전망'에 따르면, 세계 의료 산업은 역사적인 전환점에 서 있으며, AI와 첨단 기술이 혁신적인 성장 기회와 생산성 향상의 기회를 가속화하고 있습니다. 이는 거시적인 차원의 변화로, 정밀 진단의 전략적 우선순위를 체계적으로 높이고 있으며, 핵의학 영상 진단은 그 중에서도 기술적으로 가장 선진적이고 임상적으로 가장 영향력 있는 분야 중 하나입니다. 이러한 구조적 수요 요인들이 복합적으로 작용하고, 인구 동향, 역학, 기술 및 정책에 힘입어, 예측 기간 동안 핵의학 영상 진단 장비 시장은 모든 주요 응용 분야 및 지역 시장에서 지속적이고 광범위한 성장을 이룰 것으로 전망됩니다.

핵의학 영상 진단 장비 시장 - 시장 역학

암 및 심혈관질환의 부담 증가가 핵의학 영상 진단 솔루션에 대한 구조적이고 비순환적인 수요를 견인하고 있다

세계 핵의학 영상 진단 장비 시장에서 가장 중대하고 구조적으로 지속적인 수요 견인 요인은 암 및 심혈관질환으로 인한 전 세계적 부담의 증가입니다. 이들은 전 세계적으로 발병률이 가장 높고 사망률도 높은 만성 질환군에 속하며, 핵의학 영상 진단은 단순한 진단 수단에 그치지 않고 병기 분류, 치료 계획 수립, 치료 효과 평가, 재발 모니터링 등 전체 진료 과정에 걸쳐 의료 기관이 의무화하는 임상적 표준 치료법으로 자리 잡고 있습니다. 세계보건기구(WHO)의 예측에 따르면, 전 세계 신규 암 환자 수는 2022년 약 2,000만 명에서 2050년까지 3,500만 명 이상으로 증가할 것으로 예상됩니다. 이는 인구 고령화와 증가에 더해, 흡연, 음주, 비만, 대기 오염 등의 위험 요인에 대한 노출 증가로 인한 77%의 증가를 의미합니다. 인구 고령화, 임상 증거의 축적 및 보험 보상 환경의 개선으로 인해 증가하는 암 및 심혈관질환의 부담은 전 세계 핵의학 영상 진단 장비 시장에서 구조적으로 가장 견고하고 제도적으로 확고히 자리 잡은 수요 견인 요인으로 작용하고 있으며, 예측 기간 동안 모든 핵의학 영상 진단 모달리티에 걸쳐 지속적인 시장 성장을 보장하고 있습니다.

핵의학 영상 진단 장비 시장 - 시장 세분화 분석:

전 세계 핵의학 영상 진단 장비 시장은 제품, 용도, 최종사용자 및 지역별로 세분화되어 있습니다.

제품 유형별로는 SPECT 영상 시스템 부문이 핵의학 영상 진단 장비 시장에서 상당한 점유율을 차지하고 있습니다. 이는 이 치료법이 타의 추종을 불허하는 풍부한 도입 실적을 보유하고 있으며, 대학병원과 지역병원 모두에서 임상 도입을 뒷받침하는 광범위한 보험 급여 코드 적용 범위 덕분입니다. 2025년 시점에서 SPECT는 핵의학 검사 건수의 72.65%를 차지했습니다. 특히 시사하는 바가 큰 시장 동향으로, GE 헬스케어가 2025년 5월 자사의 'Aurora' 듀얼 헤드 SPECT/CT 시스템에 대해 FDA의 510(k) 승인을 획득한 점을 꼽을 수 있습니다. 이 시스템은 핵의학 분야의 기능적 및 해부학적 영상 기술을 통합하고, 딥러닝 기술을 활용해 SPECT 영상 재구성을 강화하는 'Clarify DL' 소프트웨어와 결합되어 있습니다. SPECT 부문의 폭넓은 임상적 적용 가능성, PET 대비 비용 효율성, 확립된 보험 급여 체계, 그리고 확대되는 테라노스틱스(치료와 진단의 융합) 분야로의 적용이 예측 기간 동안 주요 성장 요인이 될 것입니다.

용도별로 보면 종양학은 용도 부문에서 중요한 위치를 차지하고 있으며, 초기 종양 검출 및 병기 분류부터 치료 효과 평가, 재발 모니터링, 더 나아가 테라노스틱스 치료 계획에 이르기까지, 암 치료의 전 과정에서 핵의학 영상 진단이 수행하는 지극히 중요하고 대체 불가능한 역할 덕분에 최대의 매출 점유율을 차지하고 있습니다. 의료 기관을 통한 실증의 관점에서 볼 때, GE 헬스케어는 Vizamyl, Cerianna, Flyrcado를 포함한 방사성의약품 전반에 걸친 수요 증가를 배경으로, 미국에서 역대 최대 규모의 Omni Legend PET 시스템 수주를 확보했습니다. 이는 미국의 주요 의료 시스템이 종양 진단을 위한 차세대 PET 플랫폼에 두고 있는 신뢰를 수치화한 것으로, 조달 측면에서 획기적인 성과라고 할 수 있습니다. 종합적으로 볼 때, 종양학 부문의 구조적인 수요 기반이 탄탄하고, 테라노스틱스 생태계가 확대되며, 종양 병기 분류 및 치료 효과 평가 분야에서 PET의 임상적 검증이 가속화됨에 따라, 해당 부문은 예측 기간 동안 시장에서 가장 규모가 크고 혁신 주도적인 응용 분야로서의 입지를 확고히 하고 있습니다.

핵의학 영상 진단 장비 시장 - 지역별 분석

북미는 이 지역이 자랑하는 타의 추종을 불허하는 첨단 의료 인프라, 세계 최고 밀도의 대학병원 및 암 치료 시설, 핵의학 검사의 대부분을 포괄하는 견고한 보험 보상 체계, 그리고 의료기관과 지역 병원 모두에서 가속화되는 차세대 하이브리드 PET/CT 및 SPECT/CT 시스템의 도입률에 힘입어 주도적인 위치를 차지하고 있습니다. 이 지역의 의료 기관들이 혁신 분야에서 보여주는 리더십은, 2026년 2월 지멘스 헬스인어즈와 메이요 클리닉이 전략적 제휴를 확대한 데서 명확히 드러납니다. 두 기관은 신경퇴행성 질환의 치료 및 전립선암과 전이성 간암의 관리를 강화하기 위한 확대 협약에 서명했습니다. 이러한 추세는 예측 기간 동안 북미의 주요 의료 시스템 전반에 걸쳐 첨단 PET/CT 및 SPECT/CT 시스템에 대한 체계적이고 장기적인 수요를 창출할 것입니다.

아시아태평양은 해당 지역의 암 환자 수의 급격한 증가, 의료 인프라 투자 확대, 1인당 의료비 증가, 그리고 중국, 일본, 한국, 인도 및 동남아시아 전역에서 진행 중인 의료 영상 진단 능력 현대화를 위한 정부 주도 프로그램에 힘입어 가장 빠르게 성장하는 지역 시장으로서의 입지를 굳히고 있습니다. 이러한 광범위한 지역 수요 상황을 뒷받침하듯, 휴대용 및 소형 SPECT 시스템 덕분에 지방 의료 시설에서의 접근성이 18% 확대되었습니다. 또한, PSMA 기반 방사성 추적자의 혁신으로 전립선암 영상 진단 건수가 22% 증가했습니다. 이러한 도입 지표는 아시아태평양이 막대한 환자 수와 역사적으로 미흡했던 핵의학 영상 진단 인프라 사이의 접근성 격차를 얼마나 적극적으로 해소하고 있는지를 보여줍니다. 아시아태평양은 전 세계에서 가장 빠르게 증가하는 암 환자 수, 정부 주도의 의료 현대화 프로그램, 그리고 급속히 확대되는 핵의학 전문의 및 기술자 인력을 모두 갖추고 있어, 예측 기간 동안 전 세계 핵의학 영상 진단 장비 시장에서 상업적으로 가장 역동적이고 구조적으로 중요한 성장 시장으로서의 입지를 확고히 하고 있습니다.

일본의 핵의학 영상 진단 장비 시장 - 국가별 분석

일본의 핵의학 영상 진단 장비 시장은 고령화와 암 환자 수 증가에 힘입어 꾸준한 성장을 이루고 있습니다. 병원들이 워크플로우 효율화와 진단 정확도 향상을 위해 AI 지원 및 하이브리드 영상 진단 플랫폼에 대한 투자를 확대함에 따라, 특히 종양학 및 신경학 분야에서 PET-CT 및 SPECT 시스템에 대한 수요는 계속해서 견조한 추세를 보이고 있습니다. 예를 들어, 2025년 2월, Hitachi는 AI 스타트업과 전략적 제휴를 맺고, 질병의 조기 발견을 위한 통합 영상 및 예측 분석 플랫폼 개발에 착수했습니다. 일본은 장비 교체 수요에 이끌리던 영상 진단 시장에서, 디지털 PET, 테라노스틱스, 그리고 첨단 분자 영상 진단에 초점을 맞춘, 보다 혁신 주도형 환경으로 전환되고 있습니다.

목차

제1장 핵의학 영상 진단 장비 시장 개요

제2장 주요 요약

제3장 핵의학 영상 진단 장비 주요 시장 동향

제4장 핵의학 영상 진단 장비 산업 분석

제5장 핵의학 영상 진단 장비 시장 : 높아지는 지정학적 긴장의 영향

제6장 핵의학 영상 진단 장비 시장 구도

제7장 핵의학 영상 진단 장비 시장 : 제품별

제8장 핵의학 영상 진단 장비 시장 : 용도별

제9장 핵의학 영상 진단 장비 시장 : 유통별

제10장 핵의학 영상 진단 장비 시장 : 지역별

제11장 주요 벤더 분석 : 핵의학 영상 진단 장비 산업

제12장 AnalystView의 전방위 전망

KSM 26.06.19

Nuclear Imaging Equipment Market size was valued at US$ 3,412.82 Million in 2025, expanding at a CAGR of 7.23% from 2026 to 2033.

Nuclear imaging equipment consists of specialized medical devices designed to detect radiation emitted from within the body after the administration of radioactive tracers. These machines create highly detailed, 3D functional and physiological maps of organs and tissues to diagnose and monitor conditions like cancer and heart disease. According to PwC's Global Industrial Manufacturing Sector Outlook released in February 2026, the global healthcare industry sits at a historic inflection point, with AI and advanced technologies accelerating opportunities for transformative growth and productivity a macro-level shift that is systematically elevating the strategic priority of precision diagnostics, of which nuclear imaging represents one of the most technically advanced and clinically impactful expressions. Collectively, these structural demand drives demographic, epidemiological, technological, and policy-driven position the Nuclear Imaging Equipment market for sustained, broad-based expansion across every major application vertical and geographic market over the forecast period.

Nuclear Imaging Equipment Market- Market Dynamics

Rising Cancer and Cardiovascular Disease Burden Driving Structural, Non-Cyclical Demand for Nuclear Imaging Solution

The most consequential and structurally durable demand driver in the global Nuclear Imaging Equipment market is the accelerating global burden of cancer and cardiovascular disease two of the highest-incidence, highest-mortality chronic disease categories in the world - for which nuclear imaging represents not merely a diagnostic option but an institutionally mandated clinical standard of care across staging, treatment planning, therapy response assessment, and recurrence monitoring workflows. The World Health Organization projects that new global cancer cases will rise from approximately 20 million in 2022 to over 35 million by 2050 a 77% increase driven by population aging and growth, alongside increased exposure to risk factors including tobacco use, alcohol consumption, obesity, and air pollution. The cancer and cardiovascular disease burden amplified by demographic aging, expanding clinical evidence bases, and improving reimbursement environments constitutes the most structurally robust and institutionally embedded demand driver in the global Nuclear Imaging Equipment market, ensuring sustained procurement growth across the full spectrum of nuclear imaging modalities over the forecast period.

Nuclear Imaging Equipment Market- Segmentation Analysis:

The Global Nuclear Imaging Equipment Market is segmented on the basis of Product, Application, End-User, and Region.

Based on product type, the SPECT Imaging Systems segment holds the notable share in the nuclear imaging equipment market due to the modality's unmatched installed base depth and the extensive reimbursement code coverage that underpins its clinical deployment across both academic medical centers and community hospital settings. SPECT maintained 72.65% share of nuclear imaging procedure volumes in 2025. A particularly instructive market validation is GE HealthCare's May 2025 FDA 510(k) clearance for its Aurora dual-head SPECT/CT system, which integrates functional and anatomical imaging for nuclear medicine, paired with Clarify DL software that enhances SPECT image reconstruction with deep learning technology. The SPECT segment's combination of broad clinical applicability, cost-effectiveness relative to PET, established reimbursement infrastructure, and expanding theranostic applications are the key drivers during the forecast period.

Based on application, oncology represent a significant segment under the application segment, commanding the largest revenue share owing to the critical and non-substitutable role that nuclear imaging plays across the full cancer care continuum from initial tumor detection and staging, through treatment response evaluation, to recurrence monitoring and theragnostic therapy planning. From an institutional validation standpoint, GE HealthCare secured its largest-ever order of Omni Legend PET systems in the U.S. driven by increased demand across radiopharmaceutical products including Vizamyl, Cerianna, and Flyrcado - a procurement milestone that quantifies the institutional confidence that leading U.S. health systems are placing in next-generation PET platforms for oncology diagnostics. Collectively, the oncology segment's structural demand depth, expanding theragnostic ecosystem, and the accelerating clinical validation of PET in tumor staging and treatment response assessment position it as both the market's largest and most innovation-driven application vertical over the forecast period.

Nuclear Imaging Equipment Market- Geographical Insights

North America holds a prominent position, anchored by the region's unmatched combination of advanced healthcare infrastructure, the world's highest density of academic medical centers and cancer treatment facilities, robust reimbursement frameworks covering the majority of nuclear imaging procedures, and an accelerating adoption rate for next-generation hybrid PET/CT and SPECT/CT systems across both institutional and community hospital settings. The region's institutional innovation leadership is clearly evidenced by the February 2026 expansion of the Siemens Healthineers and Mayo Clinic strategic collaboration. The two organizations signed an expanded agreement to enhance care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. A dynamic that will generate structured, long-term demand for advanced PET/CT and SPECT/CT systems across North America's leading health systems over the forecast period.

Asia-Pacific is established as the fastest-growing regional market driven by the region's rapidly expanding cancer burden, accelerating healthcare infrastructure investment, rising per-capita healthcare expenditure, and government-backed programs to modernize medical imaging capabilities across China, Japan, South Korea, India, and Southeast Asia. Reinforcing the broader regional demand picture, portable and compact SPECT systems have expanded access in rural healthcare facilities by 18%, while PSMA-based radiotracer innovations have increased prostate cancer imaging volumes by 22% deployment metrics that quantify how the Asia-Pacific region is actively bridging the access gap between its large patient population and its historically underserved nuclear imaging infrastructure. Asia-Pacific's combination of the world's fastest-growing cancer patient population, government-backed healthcare modernization programs, and rapidly expanding nuclear medicine physician and technologist workforce collectively positions the region as the most commercially dynamic and structurally consequential growth market in the global Nuclear Imaging Equipment landscape over the forecast period.

Japan Nuclear Imaging Equipment Market - Country Analysis

Japan's nuclear imaging equipment market is witnessing steady growth, supported by the country's aging population and rising cancer burden. The country continues to see strong demand for PET-CT and SPECT systems, particularly in oncology and neurology applications, as hospitals increasingly invest in AI-enabled and hybrid imaging platforms to improve workflow efficiency and diagnostic precision. For instance, in February 2025, Hitachi's formed a strategic alliance with an AI startup to develop integrated imaging and predictive analytics platforms for early disease detection. Japan is transitioning from a replacement-driven imaging market toward a more innovation-led environment focused on digital PET, theranostics, and advanced molecular imaging.

Nuclear Imaging Equipment Market- Competitive Landscape:

The global Nuclear Imaging Equipment market is characterized by a highly consolidated competitive structure, dominated by a small number of large, globally diversified medical technology companies. The prominent companies operating in the global Nuclear Imaging Equipment market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, and Mediso Medical Imaging Systems. Siemens Healthineers and GE HealthCare dominate the market with their extensive portfolios of imaging systems including hybrid PET/CT and SPECT/CT scanners, while Philips Healthcare and Canon Medical Systems also contribute significantly with high-quality imaging devices that provide enhanced resolution and greater diagnostic precision.

Recent Developments:

In November 2025, Siemens Healthineers rebranded its PET radiopharmaceutical companies PETNET Solutions Inc. and Advanced Accelerator Applications Molecular Imaging under the unified Siemens Healthineers corporate identity, effective immediately - a structural reorganization that carries profound implications for the competitive dynamics of the global nuclear imaging market.

In May 2025, GE HealthCare obtained FDA 510(k) clearance for the Aurora dual-head SPECT/CT system and Clarify DL software - with the system integrating functional and anatomical imaging for nuclear medicine, while the Clarify DL software enhances SPECT image reconstruction with deep learning technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Canon Medical Systems Corporation
  • Mediso Ltd.
  • GE HealthCare
  • MR Solutions Ltd.
  • Digirad Corporation
  • Shimadzu Corporation
  • MILabs B.V.
  • SurgicEye GmbH
  • Philips Healthcare
  • PerkinElmer
  • CMR Naviscan Corporation
  • DDD-Diagnostic A/S
  • Neusoft Medical Systems
  • Siemens Healthineers
  • Others

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • SPECT Imaging Systems
  • PET Imaging Systems
  • Planar Scintigraphy Imaging Systems

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Oncology
  • Cardiology
  • Neurology
  • Other Applications

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Imaging Centers
  • Academic & Research Centers
  • Others

GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Nuclear Imaging Equipment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nuclear Imaging Equipment Market Snippet by Product
    • 2.1.2. Nuclear Imaging Equipment Market Snippet by Application
    • 2.1.3. Nuclear Imaging Equipment Market Snippet by End-User
    • 2.1.4. Nuclear Imaging Equipment Market Snippet by Country
    • 2.1.5. Nuclear Imaging Equipment Market Snippet by Region
  • 2.2. Competitive Insights

3. Nuclear Imaging Equipment Key Market Trends

  • 3.1. Nuclear Imaging Equipment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nuclear Imaging Equipment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nuclear Imaging Equipment Market Opportunities
  • 3.4. Nuclear Imaging Equipment Market Future Trends

4. Nuclear Imaging Equipment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nuclear Imaging Equipment Market : Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nuclear Imaging Equipment Market Landscape

  • 6.1. Nuclear Imaging Equipment Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nuclear Imaging Equipment Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. SPECT Imaging Systems
    • 7.1.3. PET Imaging Systems
    • 7.1.4. Planar Scintigraphy Imaging Systems

8. Nuclear Imaging Equipment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiology
    • 8.1.4. Neurology
    • 8.1.5. Other Applications

9. Nuclear Imaging Equipment Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Imaging Centers
    • 9.1.4. Academic & Research Centers
    • 9.1.5. Others

10. Nuclear Imaging Equipment Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nuclear Imaging Equipment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nuclear Imaging Equipment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nuclear Imaging Equipment Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Nuclear Imaging Equipment Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Nuclear Imaging Equipment Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Nuclear Imaging Equipment Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Canon Medical Systems Corporation
    • 11.2.2. Mediso Ltd.
    • 11.2.3. GE HealthCare
    • 11.2.4. MR Solutions Ltd.
    • 11.2.5. Digirad Corporation
    • 11.2.6. Shimadzu Corporation
    • 11.2.7. MILabs B.V.
    • 11.2.8. SurgicEye GmbH
    • 11.2.9. Philips Healthcare
    • 11.2.10. PerkinElmer
    • 11.2.11. CMR Naviscan Corporation
    • 11.2.12. DDD-Diagnostic A/S
    • 11.2.13. Neusoft Medical Systems
    • 11.2.14. Siemens Healthineers
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기